Literature DB >> 12217729

Anti-septicaemic effect of polysaccharide from Panax ginseng by macrophage activation.

D S Lim1, K G Bae, I S Jung, C H Kim, Y S Yun, J Y Song.   

Abstract

The aim of the present research was conducted to elucidate anti-septicaemic effect of a polysaccharide (PS) isolated from Panax ginseng C.A. Meyer (Araliaceae) by nitric oxide production from stimulated macrophage. In vitro assays for the activity measurement of PS, NO production test with Greiss reagent, phagocytic activity test using zymosan and cytokines production test using ELISA kit were also conducted. In vivo anti-septicaemic activity was assessed by using C57BL/6J mice. This was done with Staphylococcus aureus infection test. PS used at 0.025 mg/kg concentration showed a potent anti-septicaemic activity (80%, survival). However, it did not directly inhibit S. aureus in a minimum inhibitory concentration (MIC) test, conducted in vitro (data not shown). Nitric oxide production via macrophage activation showed the highest value of 5.5 nmol/ml at 1 microg/ml PS. In in vitro phagocytic activity test, PS at 10 microg/ml concentration showed a potent phagocytic activity for zymosan with 167% of the control. Production of TNF-alpha by macrophage activation at 10 microg/ml of PS was 96% lysis of L929. Also production of IL-1 and IL-6 by stimulation of macrophage with 100 microg/ml PS dose increased to 235 pg/ml and 0.47 ng/ml, respectively. The low mortality of PS treated (0.025 mg/kg) infected mice was concurrent with decreased bacterial content in the blood. Nitric oxide production in S. aureus infected mice whose macrophage was stimulated by PS (0.025 mg/kg) increased approximately 4 times than the untreated S. aureus infected group at 24 and 48 h incubation. In the PS treated (0.025 mg/kg) group, the intracellular concentration of S. aureus in macrophages decreased approximately by 50%, compared with the untreated group. Combine treatment with PS (0.025 mg/kg body weight) and vancomycin (10 mg/kg B.W.) resulted in 100% survival of the animals, whereas only 67% or 50% of the animals survived, respectively, when treated with PS or vancomycin alone. These results suggest that PS from Panax ginseng possess a potent anti-septicaemic activity by stimulating macrophage and a potentiality as an immunomodulator against sepsis occurred by Staphylococcus aureus. Copyright 2002 The British Infection Society

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217729     DOI: 10.1053/jinf.2002.1007

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  16 in total

1.  Successful treatment of canine open cervix-pyometra with Yun-Nan-Pai-Yao, a Chinese herbal preparation.

Authors:  B Salgado; R Paramo; H Sumano
Journal:  Vet Res Commun       Date:  2007-05       Impact factor: 2.459

Review 2.  A Review on Medicinal Plants Used in the Management of Respiratory Problems in Ethiopia over a Twenty-Year Period (2000-2021).

Authors:  Abebe Ayele Haile; Berhanu Abraha Tsegay; Ali Seid; Wubet Adnew; Admasu Moges
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-27       Impact factor: 2.650

3.  Reduction of SARS-CoV-2 viral load in exhaled air by antiseptic chewing gum: a pilot trial.

Authors:  F Pfab; B Buelow-Johansen; D Alber; M Kriner; O Kornmann; M Stuermer
Journal:  Infection       Date:  2022-10-19       Impact factor: 7.455

4.  A placebo-controlled trial of Korean red ginseng extract for preventing influenza-like illness in healthy adults.

Authors:  Ki-Chan Ha; Min-Gul Kim; Mi-Ra Oh; Eun-Kyung Choi; Hyang-Im Back; Sun-Young Kim; Eun-Ok Park; Dae-Young Kwon; Hye-Jeong Yang; Min-Jeong Kim; Hee-Joo Kang; Ju-Hyung Lee; Kyung-Min Choi; Soo-Wan Chae; Chang-Seop Lee
Journal:  BMC Complement Altern Med       Date:  2012-02-08       Impact factor: 3.659

Review 5.  Ginseng, the natural effectual antiviral: Protective effects of Korean Red Ginseng against viral infection.

Authors:  Kyungtaek Im; Jisu Kim; Hyeyoung Min
Journal:  J Ginseng Res       Date:  2015-09-16       Impact factor: 6.060

6.  Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza.

Authors:  Lisa M Alleva; Charles Cai; Ian A Clark
Journal:  Evid Based Complement Alternat Med       Date:  2009-09-24       Impact factor: 2.629

7.  Ginseng, the 'Immunity Boost': The Effects of Panax ginseng on Immune System.

Authors:  Soowon Kang; Hyeyoung Min
Journal:  J Ginseng Res       Date:  2012-10       Impact factor: 6.060

8.  The ginsenoside metabolite compound K, a novel agonist of glucocorticoid receptor, induces tolerance to endotoxin-induced lethal shock.

Authors:  Chul-Su Yang; Sung-Ryong Ko; Byung-Goo Cho; Dong-Min Shin; Jae-Min Yuk; Shengjin Li; Jin-Man Kim; Ronald M Evans; Jun-Sub Jung; Dong-Keun Song; Eun-Kyeong Jo
Journal:  J Cell Mol Med       Date:  2007-12-05       Impact factor: 5.310

9.  Antiviral activity of 20(R)-ginsenoside Rh2 against murine gammaherpesvirus.

Authors:  Soowon Kang; Kyungtaek Im; Geon Kim; Hyeyoung Min
Journal:  J Ginseng Res       Date:  2016-09-01       Impact factor: 6.060

10.  Nonsaponin fractions of Korean Red Ginseng extracts prime activation of NLRP3 inflammasome.

Authors:  Byung-Cheol Han; Huijeong Ahn; Jiseon Lee; Eunsaem Jeon; Sanghoon Seo; Kyoung Hwa Jang; Seung-Ho Lee; Cheon Ho Kim; Geun-Shik Lee
Journal:  J Ginseng Res       Date:  2016-10-08       Impact factor: 6.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.